Last 15,000 KRW
Change Today -150.00 / -0.99%
Volume 26.0K
As of 2:10 AM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

jw pharmaceutical (001060) Snapshot

Open
15,000
Previous Close
15,150
Day High
15,250
Day Low
14,900
52 Week High
04/17/14 - 19,200
52 Week Low
11/13/13 - 13,286
Market Cap
220.1B
Average Volume 10 Days
31.0K
EPS TTM
173.00
Shares Outstanding
14.7M
EX-Date
12/27/13
P/E TM
86.7x
Dividend
125.00
Dividend Yield
0.83%
Current Stock Chart for JW PHARMACEUTICAL (001060)

Related News

No related news articles were found.

jw pharmaceutical (001060) Related Businessweek News

No Related Businessweek News Found

jw pharmaceutical (001060) Details

JW Pharmaceutical engages in the production and sale of pharmaceutical products primarily in South Korea. Its products comprise diabetic agents, urology agents, CNS products, nephrology agents, analgesics, antipyretics, cold remedy products, antidote agents, antimicrobials, anticancer agents, antifungal agents, cardiovascular agents, gastrointestinal agents, multivitamins and antianemic agents, contact lens care and ophthalmic agents, topicals, nephrology agents, amino acid solutions, flexible I.V. containers, I.V. solutions, respiratory agents, and OBGY agents. The company also licenses its chemical entities technologies for the treatment of breast cancer and irritable bowel syndrome, as well as offers active pharmaceutical ingredients and bulk pharmaceutical products. It also exports its products to European union and Japan. The company was formerly known as Choongwae Pharma Corporation and changed its name to JW Pharmaceutical on April 21, 2011. JW Pharmaceutical was founded in 1945 and is based in Seoul, South Korea.

Founded in 1945

jw pharmaceutical (001060) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jw pharmaceutical (001060) Key Developments

JW Pharmaceutical Corporation, Annual General Meeting, Mar 21, 2014

JW Pharmaceutical Corporation, Annual General Meeting, Mar 21, 2014., at 09:00 Korea Standard Time. Location: Nambusunhwanno 2477, Seocho-gu, Seoul. Agenda: To approve audit report and business report; to consider approval of the financial statements and in the consolidated financial statements; to consider incorporation of some changes; to consider election of directors; to consider election of audit; to consider director remuneration; and to consider other references useful for making investment decisions.

JW Pharmaceutical Corporation, Annual General Meeting, Mar 15, 2013

JW Pharmaceutical Corporation, Annual General Meeting, Mar 15, 2013., at 09:00 Korea Standard Time. Location: dong, Seocho-gu. Agenda: To consider audit report and sales reporting; to consider the financial statement; to consider the appointment of director; and to consider the directors remuneration limit.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
001060:KS 15,000.00 KRW -150.00

001060 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 001060.
View Industry Companies
 

Industry Analysis

001060

Industry Average

Valuation 001060 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.5x
Price/Book 1.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JW PHARMACEUTICAL, please visit www.cwp.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.